-
1
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
The Diabetes Control and Complications Trial Research Group
-
The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
-
(1993)
N. Engl. J. Med.
, vol.329
, pp. 977-986
-
-
-
2
-
-
0033982901
-
Standards of medical care for patients with diabetes mellitus
-
American Diabetes Association
-
American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 23 (Suppl. 1): S32-S42, 2000.
-
(2000)
Diabetes Care
, vol.23
, Issue.SUPPL. 1
-
-
-
3
-
-
0036700805
-
Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients
-
Lepore G., Bruttomesso D., Nosari I., Tiengo A., Trevisan R.: Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients. Diab. Nutr. Metab. 15: 232-239, 2002.
-
(2002)
Diab. Nutr. Metab.
, vol.15
, pp. 232-239
-
-
Lepore, G.1
Bruttomesso, D.2
Nosari, I.3
Tiengo, A.4
Trevisan, R.5
-
4
-
-
0037160919
-
Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomised controlled trials
-
Pickup J., Mattock M., Kerry S.: Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. Br. Med. J. 324: 705-710, 2002.
-
(2002)
Br. Med. J.
, vol.324
, pp. 705-710
-
-
Pickup, J.1
Mattock, M.2
Kerry, S.3
-
5
-
-
0033661254
-
Pharmacokinetics and pharmacodymanics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin and continuous subcutaneous infusion of insulin lispro
-
Lepore M., Pampanelli S., Fanelli C., Porcellati F., Bartocci L., Di Vincenzo A., Cordoni C., Costa E., Brunetti P., Bolli G.B.: Pharmacokinetics and pharmacodymanics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49: 2142-2148, 2000.
-
(2000)
Diabetes
, vol.49
, pp. 2142-2148
-
-
Lepore, M.1
Pampanelli, S.2
Fanelli, C.3
Porcellati, F.4
Bartocci, L.5
Di Vincenzo, A.6
Cordoni, C.7
Costa, E.8
Brunetti, P.9
Bolli, G.B.10
-
6
-
-
0034033028
-
Less hypoglycaemia with insulin glargine in intensive insulin therapy for type 1 diabetes
-
U.S. Study Group of Insulin Glargine in Type 1 Diabetes
-
Ratner R.E., Hirsch I.B., Neifing J.L., Garg S.K., Mecca T.E., Wilson C.A.: Less hypoglycaemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care 23: 639-643, 2000.
-
(2000)
Diabetes Care
, vol.23
, pp. 639-643
-
-
Ratner, R.E.1
Hirsch, I.B.2
Neifing, J.L.3
Garg, S.K.4
Mecca, T.E.5
Wilson, C.A.6
-
7
-
-
0041488883
-
Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment
-
Lepore G., Dodesini A.R., Nosari I., Trevisan R.: Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment. Diabetes Care 26: 1321-1322, 2003.
-
(2003)
Diabetes Care
, vol.26
, pp. 1321-1322
-
-
Lepore, G.1
Dodesini, A.R.2
Nosari, I.3
Trevisan, R.4
-
8
-
-
0014848738
-
Mean amplitude of glycaemic excursions, a measure of diabetic instability
-
Service F.J., Molnar G.D., Rosevear J.W., Ackerman E., Gatewood L.C., Taylor WF.: Mean amplitude of glycaemic excursions, a measure of diabetic instability. Diabetes 19: 644-655, 1970.
-
(1970)
Diabetes
, vol.19
, pp. 644-655
-
-
Service, F.J.1
Molnar, G.D.2
Rosevear, J.W.3
Ackerman, E.4
Gatewood, L.C.5
Taylor, W.F.6
-
9
-
-
2942589458
-
A comparison of continuous subcutaneous insulin infusion (CSII) therapy versus multiple daily injection (MDI) therapy with premeal rapid acting insulin and glargine insulin in patients with type 1 diabetes
-
Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, New Orleans (Abstract 1900-PO)
-
Mathur R., Harmel A.L.P.: A comparison of continuous subcutaneous insulin infusion (CSII) therapy versus multiple daily injection (MDI) therapy with premeal rapid acting insulin and glargine insulin in patients with type 1 diabetes. Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, 2003, New Orleans (Abstract 1900-PO).
-
(2003)
-
-
Mathur, R.1
Harmel, A.L.P.2
-
10
-
-
2942615682
-
Short-term comparison between glargine as basal insulin and CSII in CSII-treated type 1 diabetic patients switching to MDI: The pump holiday study
-
Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, New Orleans (Abstract LB-13)
-
Torlone E., Pampanelli S., Porcellati F.: Short-term comparison between glargine as basal insulin and CSII in CSII-treated type 1 diabetic patients switching to MDI: the pump holiday study. Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, 2003, New Orleans (Abstract LB-13).
-
(2003)
-
-
Torlone, E.1
Pampanelli, S.2
Porcellati, F.3
-
11
-
-
3042780815
-
Type 1 diabetes patients can temporarily switch from continuous subcutaneous insulin infusion with insulin aspart to basal bolus therapy with insulin aspart and insulin glargine
-
(Abstract)
-
Bode B., Hirsch I., Hu P., Santiago O.: Type 1 diabetes patients can temporarily switch from continuous subcutaneous insulin infusion with insulin aspart to basal bolus therapy with insulin aspart and insulin glargine. Diabetologia 46 (Suppl. 213): A270, 2003 (Abstract).
-
(2003)
Diabetologia
, vol.46
, Issue.SUPPL. 213
-
-
Bode, B.1
Hirsch, I.2
Hu, P.3
Santiago, O.4
-
12
-
-
2942587682
-
Randomized, prospective trial of CSII with glargine in children: A preliminary report
-
Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, New Orleans (Abstract 192-OR)
-
Boland E., Weinzimer S., Ahern J.A., Steffen A., Tamborlane W.: Randomized, prospective trial of CSII with glargine in children: a preliminary report. Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, 2003, New Orleans (Abstract 192-OR).
-
(2003)
-
-
Boland, E.1
Weinzimer, S.2
Ahern, J.A.3
Steffen, A.4
Tamborlane, W.5
-
13
-
-
0036110458
-
Diabetes management in new millennium using insulin pump therapy
-
Bode B.W., Sabbah H.T., Gross T.M., Fredrickson L.P., Davidson P.C.: Diabetes management in new millennium using insulin pump therapy. Diabetes Metab. Res. Rev. 18 (Suppl. 1): S14-S20, 2002.
-
(2002)
Diabetes Metab. Res. Rev.
, vol.18
, Issue.SUPPL. 1
-
-
Bode, B.W.1
Sabbah, H.T.2
Gross, T.M.3
Fredrickson, L.P.4
Davidson, P.C.5
-
14
-
-
0021264112
-
Insulin pharmacokinetics
-
Binder C., Lauritzen T., Faber O., Pramming S.: Insulin pharmacokinetics. Diabetes Care 7: 188-199, 1984.
-
(1984)
Diabetes Care
, vol.7
, pp. 188-199
-
-
Binder, C.1
Lauritzen, T.2
Faber, O.3
Pramming, S.4
-
15
-
-
0029927589
-
Insulin pump therapy: Acceptable alternative to injection therapy
-
Marcus A.O., Fernandez M.P.: Insulin pump therapy: acceptable alternative to injection therapy. Postgrad. Med. 99: 125-143, 1996.
-
(1996)
Postgrad. Med.
, vol.99
, pp. 125-143
-
-
Marcus, A.O.1
Fernandez, M.P.2
-
16
-
-
0029912364
-
Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes
-
Bode B.W., Steed R.D., Davidson P.C.: Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 19: 324-327, 1996.
-
(1996)
Diabetes Care
, vol.19
, pp. 324-327
-
-
Bode, B.W.1
Steed, R.D.2
Davidson, P.C.3
-
17
-
-
0032710719
-
Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycaemia, improve metabolic control and enhance coping in adolescents with type 1 diabetes
-
Boland E.A., Grey M., Osterle A., Fredrickson L., Tamborlane W.: Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycaemia, improve metabolic control and enhance coping in adolescents with type 1 diabetes. Diabetes Care 22: 1799-1784, 1999.
-
(1999)
Diabetes Care
, vol.22
, pp. 1784-1799
-
-
Boland, E.A.1
Grey, M.2
Osterle, A.3
Fredrickson, L.4
Tamborlane, W.5
-
18
-
-
0023791423
-
Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial
-
DCCT Research Group
-
DCCT Research Group: Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care 11: 567-573, 1988.
-
(1988)
Diabetes Care
, vol.11
, pp. 567-573
-
-
-
19
-
-
0036360661
-
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: Efficacy, acceptability and quality of life
-
Bruttomesso D., Pianta A., Crazzolara D., Scaldaferri E., Lora L., Guarneri G., Mongillo A., Gennaro R., Miola M., Moretti M., Confortin L., Beltramello G.P., Pais M., Baritussio A., Casiglia E., Tiengo A.: Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. Diabet. Med. 19: 628-634, 2002.
-
(2002)
Diabet. Med.
, vol.19
, pp. 628-634
-
-
Bruttomesso, D.1
Pianta, A.2
Crazzolara, D.3
Scaldaferri, E.4
Lora, L.5
Guarneri, G.6
Mongillo, A.7
Gennaro, R.8
Miola, M.9
Moretti, M.10
Confortin, L.11
Beltramello, G.P.12
Pais, M.13
Baritussio, A.14
Casiglia, E.15
Tiengo, A.16
-
20
-
-
0036426805
-
Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study
-
Orchard T.J., Chang Y.F., Ferrell R.E., Petro N., Ellis D.E.: Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int. 62: 963-970, 2002
-
(2002)
Kidney Int.
, vol.62
, pp. 963-970
-
-
Orchard, T.J.1
Chang, Y.F.2
Ferrell, R.E.3
Petro, N.4
Ellis, D.E.5
|